Key Points There’s a lot of hype surrounding robotaxis. Cathie Wood, CEO of Ark Invest, believes robotaxis will one …

Valued at a market cap of $181 million, Ag Growth International (TSX: AFN) has grossly underperformed the broader markets …

latest news

Illustration by Tracy Worrall 8 min read5 hr Campaigning in Makerfield, Andy Burnham threatened Thames Water with …

Lightspeed is raising $250 million for Lightspeed India Partners V, a new early-stage fund dedicated entirely to AI companies …

Sony’s new ULT range of speakers stretches from the relatively manageable $450 ULT Tower 5 to the frankly ridiculous …

When MIT mechanical engineering student Daphne Wang arrived for her internship at the Muscogee Creek Nation Department of Health …

Dividend stocks can be powerful tools for long-term wealth creation, offering investors the potential for both capital appreciation and …

Bloom Energy stock is in the spotlight this week because of its role in the beleaguered data center project …

Key Points Based on Bitcoin’s historical four-year cycles, 2027 could be a winning year for investors in the top …

Thirty years can forgive a lot of investing mistakes. Start by 35, and you don’t necessarily need the next …

SpaceX stock has wavered this month after hitting the crucial resistance at $158. This consolidation has coincided with share …

Key Points CRISPR Therapeutics is transitioning into a commercial-stage company with its pioneering gene-editing treatment, CASGEVY. Vertex Pharmaceuticals maintains …